Subscribe to our Newsletters !!
Out there, in the fossil beds of Illinois, imposin
Realizing that contamination risks made 70% of rec
This doesn't feel like another one of my English e
Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referre
Alembic Pharmaceuticals Limited (Alembic) announce
'Simplicity' seems to be the perfect word to descr
Dear Readers,Welcome to the latest issue of The Magazine
Corning Incorporated will highlight its hottest technologies that support the advancement of 3D cell culture, automation, and drug discovery in this year’s virtual Society for Laboratory Automation and Screening (SLAS) seminar on Jan. 25 through 27.
Now more than ever, tools used to ease scale-up, reproducibility, and consistency of 3D cell culture are helping empower critical research required to solve the industry’s most pressing issues.
Corning will share the newest products in its 3D mobile culture portfolio, such as Matrigel® matrix-3D plates, which can offer a more consistent, ready-to-use cell culture format to support organoid and spheroid culture models and reduce workflow steps. Also featured is Corning® Matrigel matrix for organoid culture, a vialed solution that is validated to support growth and differentiation of organoid culture and can also be qualified to form stable”3D dome” structures commonly used in organoid culture.
New Corning Elplasia® plates, which will be highlighted at the conference, feature microcavity technologies for high volume spheroid creation, and Corning 3D clear tissue clearing reagent allows for quick and effortless imaging of 3D cultures. These new products are designed to deal with high throughput imaging and screening for 3D cell culture, while maintaining reproducibility and consistency – common obstacles to widespread adoption of 3D workflows.
Corning Life Sciences specialists – including John M. Tobin, vice president and general manager- will be available to discuss how these tools are being used to research and develop treatments for many different diseases and in other critical areas of research. Programs for all these tools include drug screening, cancer and stem cell biology, 3D tissue engineering, immunology, immuno-oncology, and personalized medicine.
Moreover, Corning will showcase its anti aging and disease modeling solutions used in diagnostic workflows, research and vaccine development, in addition to efforts related to the COVID-19 response. The development of complex 3D models such as these can aid in studying virus infectivity, helping to identify the most effective ways to treat and protect against disease. Other helpful tools, such as Corning robotic tips and assay microplates, are used in diagnostic workflows, and upstream options in bioproduction support vaccine development.
Corning and its customers will also offer several presentations during the virtual SLAS meeting including:
Tutorials 1. Monday, Jan. 25, 2021 12:30 – 1 p.m. EST Tutorial Session: “Gut-in-a-Dish” Model for Developing Personalized Therapies for Chronic Inflammatory Diseases Presented by: Soumita Das, assistant professor, Dept. of Pathology, chief scientific director, HUMANOID, University of California San Diego
2.Wednesday, Jan. 27, 2021 1:30 – 2 p.m. EST
Tutorial Session: High throughput Applications with Organoids Presented by: Hilary Sherman, senior scientist, Corning Life Sciences To learn more about how Corning is helping enable advancements in 3D cell culture with innovative technologies and workflow solutions, view the company’s digital booth #11 and schedule a virtual meeting with a member of the Corning executive team.
